APA (7th ed.) Citation

van Veggel, B., Madeira R Santos, J. V., Hashemi, S., Paats, M., Monkhorst, K., Heideman, D., . . . de Langen, A. (2020). Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer. Lung Cancer (01695002), 141, 9. https://doi.org/10.1016/j.lungcan.2019.12.013

Chicago Style (17th ed.) Citation

van Veggel, B., et al. "Osimertinib Treatment for Patients with EGFR Exon 20 Mutation Positive Non-small Cell Lung Cancer." Lung Cancer (01695002) 141 (2020): 9. https://doi.org/10.1016/j.lungcan.2019.12.013.

MLA (9th ed.) Citation

van Veggel, B., et al. "Osimertinib Treatment for Patients with EGFR Exon 20 Mutation Positive Non-small Cell Lung Cancer." Lung Cancer (01695002), vol. 141, 2020, p. 9, https://doi.org/10.1016/j.lungcan.2019.12.013.